Dergiler / art / 2017 / Cilt: 32 - Sayı: 2

Primary Sjögren’s Syndrome Adversely Affects the Female Sexual Function Assessed by the Female Sexual Function Index: A Case-Control Study

Dergi
art
Sayfa
123–128
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Clinical management of female patients with pSS should cover the assessment of their sexual functionality and taking the necessary precautions to maintain satisfactory quality of life and treatment outcome

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aims to evaluate the sexual function of females with primary Sjögren’s syndrome (pSS) in comparison to healthy females by using the Female Sexual Function Index (FSFI).Patients and methods: This case-control study included 31 female patients (mean age 46.0±10.2 years; range 30 to 68 years) with pSS and 27 healthy females (mean age 44.2±8.5 years; range 30 to 55 years) as control group.
📊
Temel Bulgular & Veri:The sexual function of the participants was assessed by 19-item FSFI.Results: Mean duration of pSS in the patient group was 35.9 months (range 3 to 264 months).
💡
Sonuç & Katkı:Clinical management of female patients with pSS should cover the assessment of their sexual functionality and taking the necessary precautions to maintain satisfactory quality of life and treatment outcome
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: This study aims to evaluate the sexual function of females with primary Sjögren’s syndrome (pSS) in comparison to healthy females by using the Female Sexual Function Index (FSFI).Patients and methods: This case-control study included 31 female patients (mean age 46.0±10.2 years; range 30 to 68 years) with pSS and 27 healthy females (mean age 44.2±8.5 years; range 30 to 55 years) as control group. The sexual function of the participants was assessed by 19-item FSFI.Results: Mean duration of pSS in the patient group was 35.9 months (range 3 to 264 months). Significantly higher number of pSS patients reported positive history for vaginal infection compared to controls (n=26, 83.9% vs n=7, 25.9%, respectively; p<0.001) without any difference in endocervical culture result. Cervical smear assessment revealed more inflammation and atrophy in patient group compared to control group (p=0.001). Mean FSFI total score was significantly lower in patient group than control group (18.9±9.9 vs 25.1±5.1, respectively; p=0.004). Similarly, five out of six domains of FSFI -arousal, lubrication, orgasm, satisfaction, and pain- were significantly lower in patient group. FSFI total and subscale scores, except for pain, were found to be negatively correlated with duration of pSS.Conclusion: The pSS causes sexual dysfunction in female patients. Furthermore, as disease duration increases, female sexual function decreases. Clinical management of female patients with pSS should cover the assessment of their sexual functionality and taking the necessary precautions to maintain satisfactory quality of life and treatment outcome

🔖

Bu Makaleye Atıf Yap

YILDIZ, Ç., KARAKUŞ, S., AKKAR, Ö. B., ŞAHİN, A., BOZKURT, B., YANIK, A. (2017). Primary Sjögren’s Syndrome Adversely Affects the Female Sexual Function Assessed by the Female Sexual Function Index: A Case-Control Study. art, Cilt: 32 - Sayı: 2, 123–128. https://ajindex.com/articles/161898

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Luciano N, Valentini V, Calabrò A, Elefante E, Vitale A, Baldini C, et al. One year in review 2015: Sjögren’s syndrome. Clin Exp Rheumatol 2015;33:259-71
  2. Maslinska M, Przygodzka M, Kwiatkowska B, Sikorska-Siudek K. Sjögren’s syndrome: still not fully understood disease. Rheumatol Int 2015;35:233-41
  3. Cornec D, Jamin C, Pers JO. Sjögren’s syndrome: where do we stand, and where shall we go? J Autoimmun 2014;51:109-14
  4. Konttinen YT, Porola P, Konttinen L, Laine M, Poduval P. Immunohistopathology of Sjögren’s syndrome. Autoimmun Rev 2006;6:16-20
  5. Schoofs N. Caring for women living with Sjögren’s syndrome. J Obstet Gynecol Neonatal Nurs 2003;32:589-93
  6. Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clin Epidemiol 2014;6:247-55
  7. Birlik M, Akar S, Gurler O, Sari I, Birlik B, Sarioglu S, et al. Prevalence of primary Sjogren’s syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract 2009;63:954-61
  8. Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N, et al. The prevalence of Sjögren’s syndrome in adult women. Scand J Rheumatol 2006;35:379-83
  9. Brandt JE, Priori R, Valesini G, Fairweather D. Sex differences in Sjögren’s syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ 2015;6:19
  10. Reksten TR, Jonsson MV. Sjögren’s syndrome: an update on epidemiology and current insights on pathophysiology. Oral Maxillofac Surg Clin North Am 2014;26:1-12
  11. Lehrer S, Bogursky E, Yemini M, Kase NG, Birkenfeld A. Gynecologic manifestations of Sjögren’s syndrome. Am J Obstet Gynecol 1994;170:835-7
  12. Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM. Obstetric and gynaecological profile in patients with primary Sjögren’s syndrome. Ann Rheum Dis 1994;53:569-73
  13. Mulherin DM, Sheeran TP, Kumararatne DS, Speculand B, Luesley D, Situnayake RD. Sjögren’s syndrome in women presenting with chronic dyspareunia. Br J Obstet Gynaecol 1997;104:1019-23. 14. van Nimwegen JF, Arends S, van Zuiden GS, Vissink A, Kroese FG, Bootsma H. The impact of primary Sjögren’s syndrome on female sexual function. Rheumatology (Oxford) 2015;54:1286-93
  14. Stephenson KR, Meston CM. The conditional importance of sex: exploring the association between sexual well-being and life satisfaction. J Sex Marital Ther 2015;41:25-38
  15. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the Euro